| Multi-omics integration to identify the genetic expression and protein signature of dilated and ischemic cardiomyopathy K Portokallidou, N Dovrolis, G Ragia, N Atzemian, G Kolios, ... Frontiers in Cardiovascular Medicine 10, 1115623, 2023 | 5 | 2023 |
| Distinct pleiotropic effects of direct oral anticoagulants on cultured endothelial cells: a comprehensive review N Atzemian, D Kareli, G Ragia, VG Manolopoulos Frontiers in Pharmacology 14, 1244098, 2023 | 3 | 2023 |
| Implementing pharmacogenetic testing in fluoropyrimidine-treated cancer patients: DPYD genotyping to guide chemotherapy dosing in Greece G Ragia, A Maslarinou, N Atzemian, E Biziota, T Koukaki, C Ioannou, ... Frontiers in Pharmacology 14, 1248898, 2023 | 3 | 2023 |
| SLCO1B1 c.521T>C gene polymorphism decreases hypoglycemia risk in sulfonylurea-treated type 2 diabetic patients G Ragia, N Atzemian, A Maslarinou, VG Manolopoulos Drug Metabolism and Personalized Therapy 37 (4), 347-352, 2022 | 2 | 2022 |
| DNA methylation of ADAMTS7 gene promoter in direct oral anticoagulant-induced bleeding in patients with atrial fibrillation N Atzemian, G Ragia, T Thomopoulos, V Tsaliki, G Kolios, G Chalikias, ... European Heart Journal 44 (Supplement_2), ehad655. 2854, 2023 | | 2023 |
| Beyond the Rhythm: In Silico Identification of Key Genes and Therapeutic Targets in Atrial Fibrillation N Atzemian, N Dovrolis, G Ragia, K Portokallidou, G Kolios, ... Biomedicines 11 (10), 2632, 2023 | | 2023 |
| Therapeutic Drug Monitoring (TDM) Implementation in Public Hospitals in Greece in 2003 and 2021: A Comparative Analysis of TDM Evolution over the Years G Voulgaridou, T Paraskeva, G Ragia, N Atzemian, K Portokallidou, ... Pharmaceutics 15 (9), 2181, 2023 | | 2023 |
| Unraveling Potential Pharmacological Target Genes from Transcriptomic Profiles in the Development of Persistent Atrial Fibrillation: A Bioinformatics Approach N Atzemian, N Dovrolis, G Ragia, G Kolios, V Manolopoulos EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 78 (SUPPL 1), S17-S18, 2022 | | 2022 |
| Direct oral anticoagulant-related bleeding in atrial fibrillation patients alters DNA methylation of NOS3 and KDR genes G Ragia, T Thomopoulos, N Atzemian, V Tsaliki, G Chalikias, G Kolios, ... EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 78 (SUPPL 1), S3-S3, 2022 | | 2022 |
Vangelis ManolopoulosProfessor of Pharmacology, Pharmacogenomics, and Precision Medicine, Democritus University of ThraceVerified email at med.duth.gr
